🇺🇸 FDA
Pipeline program

Yimitasvir Phosphate Capsule

PCD-DDAG181PA-18-001

Phase 1 small_molecule completed

Quick answer

Yimitasvir Phosphate Capsule for Renal Impairment is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Renal Impairment
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials